Mark Fankhauser
Nurse Practitioner · Edinburg, TXNPI 1841906005
Payments from drug & device makers
Across 319 payments — averaging $25.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Dexcom, Inc.$959
- Corcept Therapeutics$914
- Novo Nordisk$837
- Insulet Corporation$535
- Lilly USA, LLC$443
- plus $3K from 21 others
What the payments were for
- Travel & lodging$81810%
- Food & beverage$7,18689%
- Education$1051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 29 | $1,910 |
| Dexcom, Inc. | 32 | $959 |
| Corcept Therapeutics | 56 | $914 |
| Novo Nordisk | 32 | $837 |
| Insulet Corporation | 13 | $535 |
| Lilly USA, LLC | 34 | $443 |
| Amgen | 28 | $354 |
| Mannkind Corporation | 16 | $315 |
| Xeris Pharmaceuticals, Inc. | 15 | $264 |
| Radius Health, Inc. | 13 | $241 |
| Ascensia Diabetes Care US Inc. | 5 | $202 |
| Tandem Diabetes Care, Inc. | 2 | $153 |
| Madrigal Pharmaceuticals | 5 | $150 |
| Boehringer Ingelheim | 6 | $134 |
| Recordati_rare_diseases_inc. | 6 | $133 |
| Averitas Pharma Inc. | 6 | $129 |
| Novartis | 3 | $72 |
| Cequr Corporation | 2 | $62 |
| Bayer | 3 | $60 |
| Kyowa Kirin, Inc. | 2 | $52 |
| Antares Pharma, Inc. | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| AstraZeneca(2 entities) | 2 | $34 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Halozyme Inc | 1 | $20 |
| Getinge USA Sales, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,108 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 14 | $567,598 |
| OzempicSemaglutide | 413 | $528,236 |
| MounjaroTirzepatide | 310 | $435,251 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 177 | $162,508 |
| Tresiba Flextouch U-200Insulin Degludec | 131 | $149,718 |
| JardianceEmpagliflozin | 115 | $138,622 |
| TrulicityDulaglutide | 68 | $120,360 |
| FarxigaDapagliflozin Propanediol | 121 | $116,407 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 47 | $68,647 |
| Xigduo XrDapaglifloz Propaned/Metformin | 62 | $62,611 |
| TymlosAbaloparatide | 15 | $44,347 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 59 | $38,107 |
| Tresiba Flextouch U-100Insulin Degludec | 58 | $35,647 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 37 | $35,326 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $31,665 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Corcept TherapeuticsKorlym | $914 | $567,59814 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $837 | $561,796457 claims |
| Lilly USA, LLCMounjaro, Trulicity | $443 | $555,611378 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance, Trijardy Xr, Synjardy, Tradjenta | $134 | $372,617365 claims |
| AstraZenecaFarxiga | $34 | $116,407121 claims |
| Radius Health, Inc.Tymlos | $241 | $44,34715 claims |
| AmgenProlia | $354 | $19,86012 claims |
| BayerKerendia | $60 | $13,64511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Edinburg
- Angelica LozaresEdinburg$19K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.